 (European Carotid Surgery Trial) and NASCET (North American
Symptomatic Carotid Endarterectomy Trial) demonstrated that CEA was unable to reduce the subsequent
neurologic event rates in patients with symptoms of cerebral ischemia and bifurcation stenosis of <50% diameter
reduction and was actually associated with increased
morbidity compared with medical management.33-35
NASCET and ECST both demonstrated the beneﬁt